Note that some links may require subscriptions.
Shifting position, the Justice Department told an appeals court that it should uphold last December’s ruling in federal district court that the Affordable Care Act is unconstitutional. (The Hill)
The Democratic Republic of the Congo’s Ebola outbreak has now topped 1,000 cases, the country’s health ministry said. (NBC News)
Air pollution may lower sperm count and quality, a mouse study suggested. (New Scientist)
Following an Oklahoma state Supreme Court ruling that Purdue Pharma and two other firms must face trial in May over their opioid marketing, Purdue reportedly is ready to settle. (Reuters)
Sugar-sweetened beverages tied to greater risk of death from cardiovascular disease. (Medical News Today)
A case report explores how esophageal cancer associated with chronic acid reflux is among the most rapidly growing cancer in the U.S. (Undark)
Such a thing as too much: Excessive vitamin D may lead to a higher risk of falling and slower reaction times among older people. (Medical News Today)
Aldeyra’s nonsteroidal drug targeting aldehyde metabolism, reproxalap, succeeded in a phase III trial for treating seasonal allergic conjunctivitis, the firm said.
Johnson & Johnson and Bayer will pay $775 million to settle lawsuits over severe bleeding in patients treated with rivaroxaban (Xarelto). (The New York Times)
And Duke University agreed on a $112.5-million settlement in a research fraud case — involving falsified data on murine lung function — making a nice payday for the whistleblower who brought the case to light. (NPR)
A House panel will discuss what to do about surprise medical bills. (Vox)
The Federal Trade Commission isn’t happy with Bristol-Myers Squibb’s planned merger with Celgene. (Reuters)
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: [email protected]